Buy Shipping Corporation of India at Rs 67.1-68.8, Stop loss at Rs 66.4, Target at Rs 71.1-75.2

Buy Sintex Industries at Rs 92.1-95.5, Stop loss at Rs 89.5, Target at Rs 101.4-110.7

Buy Pantaloon Retail at Rs 175.10, Stop loss at Rs 172, Target at Rs 181

Buy BEML at Rs 548.20, Stop loss at Rs 544, Target at Rs 556

Related posts:

1. Free Trading Tips – 12 Jan 2012
2. Free Intraday Tips – 5 Jan 2012
3. Free Day Trading Tips – 29 March 2011

Buy ABB at Rs 628.8-635.4, Stop loss at Rs 624, Target at Rs 646.8-664.8

Buy SAIL (Steel Authority of India) at Rs 89.2-90.7, Stop loss at Rs 88.4, Target at Rs 93.1-96.9

Related posts:

1. Free Intraday Tips – 5 Jan 2012
2. Free Day Trading Stock Tips – 09 March 2010
3. Free Day Trading Tips – 29 March 2011

Buy Tata Motors at Rs 195-198.5, Stop loss at Rs 193.1, Target at Rs 203.9-212.8

Buy ONGC at Rs 262.5-265.1, Stop loss at Rs 261.6, Target at Rs 268.6-274.7

Related posts:

1. Free Trading Tips – 12 Jan 2012
2. Free Day Trading Tips – 06 Feb 2012
3. Free Day Trading Tips – 29 March 2011

Sell REI Agro at Rs 22.2-22.5, Stop Loss at Rs 22.8, Target at Rs 20.8-21.7

Buy Ambuja cement at Rs 159-160.2, Stop Loss at Rs 158.2, Target at Rs 162.3-165.6

Related posts:

1. Free Intraday Tips – 3 Nov 2011
2. Free Day Trading Tips – 05 Sept 2011
3. Free Day Trading Tips – 17 May 2011

Buy RCF around Rs 81.30-84.30, stop loss Rs 79.40, book profit at Rs 89.10-96.90

Sell Crompton Greaves around Rs 148.20-145.90, stop loss Rs 149.30, cover short at Rs 142.50-136.70

Related posts:

1. Free Intraday Stock Tips – 01 April 2010
2. Free Day Trading Tips – 29 March 2011
3. Free Intraday Stock Tips – 18 May 2010

Base business to grow over 18% CAGR:

We expect robust growth in base business (18% CAGR growth over FY10-13E) driven by growth in US generics (18.2% CAGR), Latam business (19.4% CAGR over FY10-13E) & domestic formulation business (18.4% CAGR over FY10-13E). The growth in US market can be attributed to growth in high margin derma products, hormonal products & others. Out of the 22 ANDAs filed for derma products, the company has approval of 18 ANDAs. Other opportunities in US market mainly include Oxycodone, Cutivate, & calcipotriene. Domestic market is expected to grow mainly on the back of new launches in key therapeutic segments viz respiratory, dermatology & anti-infectives. Completion of successful restructuring for Brazilian operations to add to the growth on Latam business.

EBITDA margins to improve by 160bps to 27.4% in FY12:

Company recently received an USFDA approval for Norethindrone & Ethinyl Estradiol tablets which marks company’s fourth entry into hormonal product portfolio & third in oral contraceptive segment. Company’s total pipeline for these products is worth ~ USD 141mn (IMS Health, Dec 2010). These products are very high margin products & presence of few players leads to higher profit realization.

Attractive First to File opportunity :

The company has a total of 11 Para IV (Mkt size – USD 6.8bn) of which the company has sole FTF (Mkt size – USD 1.6bn) opportunities on four products. Out of the four products, Malarone & Cutivate are expected to be launched in Q3FY12 & Q1FY12 respectively. This brings into account NPS/share of Rs 2 & 1.2 respectively for the company. Being FTF player it would be entitled to an exclusivity of 180 days.

R&D progress on track:

The company has total of 10 molecules in pipeline out of which two are in-licensed & one-out licensed. NCE viz Crofelemer (Mkt size – USD 80mn) & GRC15300 (USD 9bn) are progressing well and the launch is expected to happen in Q4FY12 & post FY15 respectively. This brings in NPV/share of Rs 25 & 22 respectively. Also recently the company’s NCE GRC-17536 got approval for human trials in Europe for multiple indications.

Related posts:

1. Free Day Trading Tips – 29 March 2011
2. Buy Glenmark Pharma, target of Rs 270: Sharekhan
3. Buy Torrent Pharma, target of Rs 200: Karvy

Buy SREI Infrastructure Finance at CMP Rs 43.95, Stop Loss: 42.25, Target 48

Buy Canara Bank at Rs 622.45, stop loss Rs 600, target Rs 660

Buy Chennai Petro at Rs 212.50 and on dips to Rs 208, stop loss Rs 200, target Rs 235

Buy Crompton Greaves at Rs 268.20 and Bank Of Baroda at Rs 927.90. Up side potential 4%.

Buy Mundra Port at Rs 137.95 and on dips to Rs 135, target Rs 145, stop loss Rs 132

Buy Kalpataru Power initially above Rs 123 and then on dips to Rs 118, target Rs 140, closing stop loss Rs 112

Related posts:

1. Free Day Trading Tips – 28 March 2011
2. Buy Glenmark Pharma
3. Free Day Trading Tips – 08 Nov 2011

CSS Technergy Ltd.

BSE 590050

NSE CSSTECH

CSS Tech is engaged in providing turnkey ITES solutions adopting ICR, OMR, OCR in various e-governance projects and in end-to-end student data management for arge-scale entrance examinations. CSS also does end-to-end meter-to-cash solutions and adoption of firmware upgrades in Spot Billing Machines which are still being used on a large scale due to their highROI and high efficiency. CSS serves more than 20 million consumers across india through its utility services division in 8 states.

CSS is serving customers like FedeX,Fujitsu, PSEB,Wipro, GE, CMC,Capgemini D E Shaw, MESCOM, Mahavitaran etc. CSS expertise summary :- E-governance project planning and implementation. End to End document management One of India’s largest Utility IT Services company offering services to several DISCOMs Serving 10 top utilities in the country CSS stores, manages and maintains close to 10 million customer data on the servers in a secure manner CSS is an empanelled member of PFC for bothMDASP and GSP for R-APDRP programs of Govt Empanelled with UIDAadhaar in the highest T2,F4 category for all-India capability. CSS has its own suite of customer- proven products for each of the vertical it operates in. These solutions are used on a regular basis at CS project locations and at client deployment areas. Its suite of products includes: EBAS, MetTecaa, DMSol, Loyaltrack.

So far, performance of CSS has been lacklustre. However, in view of certain developments, CSS has much better and brighter future prospects. As company is T2F4 level categhorized by UIDAI, it has bagged contract for 22 disctricts covering the states of Bihar, West Bengal, Andhra Pradesh and Orissa. Company can cover the whole of eligible numbers with in these 22 districts and additionally also bid for other locations with different registrars. From this new business, company is eligible to capture 50 million nos of UID Project. THIS PROJECT CAN LEAD TO 200 CRORE REVENUES TO CSS IN 3 YEARS. Company has already started implementation of this prestigious project which is being done through Own Assets as well as Outsourcing. For implementation of this project, company needs to spend approx 3 lac for each work-station and total capex will be 600 lacs for 200 workstations. To raise money for this project, CSS may make preferential offer of equity shares in near future (that is why, equity for next year has been shown as 7 crores. Above estimates have been arrived at only considering orders in hand. If CSS manages to capture more orders from UID, company’s performance can be spectacular in coming years. Its current market cap is just 14 crores which is really considering:

Book Value is Rs 35.50, Scrip is available at 3.80xFY12E Eps, Scrip is trading at 2.45xFY12E Eps, So far, share price has been lying low due to lacklustre performance. However, in near future, company’s performance will witness huge improvement and share price too can climb sharply. Scrip at Cmp appears risk-free. Floating stock is low. Investors may gain 50-70% in next 6 months.

Related posts:

1. Zensar Tech – Stocks To Watch
2. Buy Glenmark Pharma
3. Educomp Solutions Limited (Educomp) – Stocks to Watch

Buy IFCI CMP 53.80 Target 58 Stop Loss 49.50

Buy JetAirways CMP – 441.35 Stoploss – 439 Target – 450

Buy TV TodayNetwork CMP – 62.10 Target – 65.50 Stoploss – 60.00

Buy Sterlite Ind CMP – 168.50 Target – 174 Stoploss – 158

Buy Ashok Leyland CMp – 56.55 Target – 60.00 Stoploss – 54

Buy United Phos CMP – 145.75 Target – 155 Stoploss – 140

Buy Mercator Lines CMP – 38.40 Target – 43 Stoploss – 35

Related posts:

1. Free Day Trading Tips – 29 March 2011
2. Free Day Trading Tips – 18 Feb 2011
3. Free Intraday Tips – 12 March 2009

Buy Andhra Bank around Rs 147.30-149.30, stop loss Rs 146, book profit at Rs 152.70-158.20

BUY LIC Housing Finance Stop Loss 193 Target 231

BUY Educomp Solutions Stop Loss 494 Target 538

BUY Arvind Stop Loss 58 Target 69

BUY Pipavav Shipyard Stop Loss 77 Target 89

Sell Gujarat NRE Coke around Rs 51.10-49.90, stop loss Rs 51.80, cover short at Rs 47.90-44.80

Related posts:

1. Free Day Trading Tips – 05 Sept 2011
2. Free Day Trading Stock Tips – 14 May 2010
3. Free Day Trading Stock Tips – 27 April 2010